<DOC>
	<DOC>NCT02328651</DOC>
	<brief_summary>This is a single-blinded randomized trial aiming to evaluate the effectiveness of Xiaoer Jiebiao Oral liquid in combination with Ribavirin treatment on patients with hand-foot-mouth disease compared with the controlgroup that recieve only libavirin treatment.</brief_summary>
	<brief_title>Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease</brief_title>
	<detailed_description />
	<mesh_term>Mouth Diseases</mesh_term>
	<mesh_term>Foot-and-Mouth Disease</mesh_term>
	<mesh_term>Hand, Foot and Mouth Disease</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>subjects should meet all of the following diagnosed as handfootmouth disease grade I or grade II; body temperature at admission T&gt;38℃，fever length&lt;48 hours; no need for hormonotherapy or immunoglobulin therapy. signed written informed consent form subjects should be excluded if meet any of the following with history of any heart, lung, kidney or liver diseases; under any hormonotherapy, immunoglobulin therapy or any other therapy.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Mild and Moderate Severe Patients With hand_foot-mouth Disease</keyword>
</DOC>